Comment re: multicenter study of the European Assessment Group for Lysis in the Eye (EAGLE) for the treatment of central retinal artery occlusion: design issues and implications.
Hayreh
Sohan Singh
SS
D005342:Fibrinolysis; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D005451:Fluorescein Angiography; D006438:Hemodilution; D006801:Humans; D007261:Infusions, Intra-Arterial; D015337:Multicenter Studies as Topic; D011446:Prospective Studies; D016032:Randomized Controlled Trials as Topic; D012107:Research Design; D015356:Retinal Artery Occlusion / Q000188:drug therapy*; D010959:Tissue Plasminogen Activator / Q000627:therapeutic use*; D014792:Visual Acuity
D005343:Fibrinolytic Agents; D010959:Tissue Plasminogen Activator